Youngevity
International (NASDAQ: YGYI, YGYIP), a leading multi-channel lifestyle
company, today announced the pricing of its underwritten public offering of
245,398 shares of its 9.75% Series D Cumulative Redeemable Perpetual Preferred
Stock at a price to the public of $22.75 per share. Youngevity expects
approximately $5.58 million in gross proceeds from the offering, from which it
intends to use the net proceeds for working capital and other general corporate
purposes. The closing of the offering, subject to the satisfaction of customary
conditions, is expected to occur on or about December 20, 2019. The shares of
Series D Preferred Stock trade on the Nasdaq Capital Market under the symbol
“YGYIP” and will not be convertible into or exchangeable for any of the
company’s other securities. The Benchmark Company, LLC is acting as sole
book-running manager of the offering.
To view the full press release, visit http://ibn.fm/saZPe
About Youngevity International, Inc.
Youngevity International, Inc. (NASDAQ: YGYI, YGYIP), is a
multi-channel lifestyle company operating in three distinct business segments
including a commercial coffee enterprise, a commercial hemp enterprise, and a
multi-vertical omni direct selling enterprise. The company features a multi
country selling network and has assembled a virtual Main Street of products and
services under one corporate entity. YGYI offers products from the six top
selling retail categories: health/nutrition, home/family, food/beverage
(including coffee), spa/beauty, apparel/jewelry, as well as innovative
services. For investor information, please visit www.YGYI.com.
NOTE TO INVESTORS: The latest news and updates
relating to YGYI are available in the company’s newsroom at http://ibn.fm/YGYI
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
